Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Monitoring the treatment outcome in endometrial cancer patients by CEA and TATI | SpringerLink
Diagnostic Usefulness of Plasma Carcinoembryonic Antigen Levels in Acute and Chronic Liver Disease
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma | PLOS ONE
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
:max_bytes(150000):strip_icc()/breast-cancer-tumor-markers-and-tumor-marker-tests-4301102-30358af146c64584b345c51499c0d70c.png "Breast Cancer Tumor-Marker Tests")
Breast Cancer Tumor-Marker Tests
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy - ScienceDirect
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
CEA Fluctuation During a Single Fluorouracil-based Chemotherapy Cycle for Metastatic Colorectal Cancer | Anticancer Research
CEA Fluctuation During a Single Fluorouracil-based Chemotherapy Cycle for Metastatic Colorectal Cancer | Anticancer Research
Fluctuations in RECIST. Calcitonin, CEA and RECIST are | Download Scientific Diagram
Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA | SpringerLink
Within- and between-subject biological variation data for tumor markers based on the European Biological Variation Study
Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA 242 during twelve months in men and women aged 60â
A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA
Fluctuations in RECIST. Calcitonin, CEA and RECIST are | Download Scientific Diagram
Time curves (of every patient) for calcitonin (CTN) and... | Download Scientific Diagram
Fluctuations in CEA. Calcitonin, CEA and RECIST are graphed | Download Scientific Diagram
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on lon
